BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luo J, Gong T, Ma L. Chondroitin-modified lipid nanoparticles target the Golgi to degrade extracellular matrix for liver cancer management. Carbohydr Polym 2020;249:116887. [PMID: 32933700 DOI: 10.1016/j.carbpol.2020.116887] [Cited by in Crossref: 9] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Li M, Zhang Y, Zhang Q, Li J. Tumor extracellular matrix modulating strategies for enhanced antitumor therapy of nanomedicines. Mater Today Bio 2022;16:100364. [PMID: 35875197 DOI: 10.1016/j.mtbio.2022.100364] [Reference Citation Analysis]
2 Li RS, Wen C, Huang CZ, Li N. Functional molecules and nano-materials for the Golgi apparatus-targeted imaging and therapy. TrAC Trends in Analytical Chemistry 2022;156:116714. [DOI: 10.1016/j.trac.2022.116714] [Reference Citation Analysis]
3 Zhao T, Zhang R, He Q, Zhou H, Song X, Gong T, Zhang Z. Partial ligand shielding nanoparticles improve pancreatic ductal adenocarcinoma treatment via a multifunctional paradigm for tumor stroma reprogramming. Acta Biomater 2022;145:122-34. [PMID: 35381402 DOI: 10.1016/j.actbio.2022.03.050] [Reference Citation Analysis]
4 Huang Y, Wang T, Yang J, Wu X, Fan W, Chen J. Current Strategies for the Treatment of Hepatocellular Carcinoma by Modulating the Tumor Microenvironment via Nano-Delivery Systems: A Review. Int J Nanomedicine 2022;17:2335-52. [PMID: 35619893 DOI: 10.2147/IJN.S363456] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Zheng G, Wang K, Chen B, Liu M, Yang W, Ning J, Cai Y, Wei M. The enhanced solubility and anti-lipase activity of citrus peel polymethoxyflavonoids extracts with liposomal encapsulation. LWT 2022;161:113395. [DOI: 10.1016/j.lwt.2022.113395] [Reference Citation Analysis]
6 Alghamdi MA, Fallica AN, Virzì N, Kesharwani P, Pittalà V, Greish K. The Promise of Nanotechnology in Personalized Medicine. JPM 2022;12:673. [DOI: 10.3390/jpm12050673] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
7 Kesharwani P, Chadar R, Sheikh A, Rizg WY, Safhi AY. CD44-Targeted Nanocarrier for Cancer Therapy. Front Pharmacol 2022;12:800481. [DOI: 10.3389/fphar.2021.800481] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Rasouli M, Fallah N, Bekeschus S. Combining Nanotechnology and Gas Plasma as an Emerging Platform for Cancer Therapy: Mechanism and Therapeutic Implication. Oxid Med Cell Longev 2021;2021:2990326. [PMID: 34745414 DOI: 10.1155/2021/2990326] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
9 Xie G, Jin S, Li H, Ai M, Han F, Dai Y, Tao W, Zhu Y, Zhao Y, Qin M. Chemical constituents and antioxidative, anti-inflammatory and anti-proliferative activities of wild and cultivated Corydalis saxicola. Industrial Crops and Products 2021;169:113647. [DOI: 10.1016/j.indcrop.2021.113647] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
10 Zhang W, Zhou Y, Xu X, Tian Y, Zhang C. A Time-Resolved-Fluorescence Lateral Flow Assay for Rapid Detection of Cholyglycine Acid for the Diagnosis of Liver Diseases. j biomater tissue eng 2021;11:2023-9. [DOI: 10.1166/jbt.2021.2781] [Reference Citation Analysis]
11 Zhang M, Xu N, Xu W, Ling G, Zhang P. Potential therapies and diagnosis based on Golgi-targeted nano drug delivery systems. Pharmacol Res 2021;175:105861. [PMID: 34464677 DOI: 10.1016/j.phrs.2021.105861] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
12 Niu Y, Xue Q, Fu Y. Natural Glycan Derived Biomaterials for Inflammation Targeted Drug Delivery. Macromol Biosci 2021;:e2100162. [PMID: 34145960 DOI: 10.1002/mabi.202100162] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Zhang Y, Qiu N, Zhang Y, Yan H, Ji J, Xi Y, Yang X, Zhao X, Zhai G. Oxygen-carrying nanoparticle-based chemo-sonodynamic therapy for tumor suppression and autoimmunity activation. Biomater Sci 2021;9:3989-4004. [PMID: 33908449 DOI: 10.1039/d1bm00198a] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
14 Zhou H, Fu J, Fu Q, Feng Y, Hong R, Li P, Wang Z, Huang X, Li F. Biotin-streptavidin-guided two-step pretargeting approach using PLGA for molecular ultrasound imaging and chemotherapy for ovarian cancer. PeerJ 2021;9:e11486. [PMID: 34113492 DOI: 10.7717/peerj.11486] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
15 Borges GSM, Lima FA, Carneiro G, Goulart GAC, Ferreira LAM. All-trans retinoic acid in anticancer therapy: how nanotechnology can enhance its efficacy and resolve its drawbacks. Expert Opin Drug Deliv 2021;:1-20. [PMID: 33896323 DOI: 10.1080/17425247.2021.1919619] [Reference Citation Analysis]
16 Zhang Z, Ma L, Luo J. Chondroitin Sulfate-Modified Liposomes for Targeted Co-Delivery of Doxorubicin and Retinoic Acid to Suppress Breast Cancer Lung Metastasis. Pharmaceutics 2021;13:406. [PMID: 33808649 DOI: 10.3390/pharmaceutics13030406] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Zhang X, Chen L, Wei YY, Yang YZ, Liu XG, Du JL, Li Q, Yu SP. Advances in organelle-targeting carbon dots. Fullerenes, Nanotubes and Carbon Nanostructures 2021;29:394-406. [DOI: 10.1080/1536383x.2020.1852217] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]